University of Miami using Qynapse's AI technology to research effects of Covid-19 on neuroimaging markers of cognitive impairment
BOSTON, Sept. 7, 2022 /PRNewswire/ -- Qynapse Inc., a medical technology company with a commercialized Artificial Intelligence (AI) powered neuroimaging analysis platform for central nervous system (CNS) disorders, is pleased to announce a collaborative …